Pau d'arco (Tabebuia avellanedae) is native to South America, where reportedly it has been used to treat a wide range of conditions, including pain, arthritis, inflammation of the prostate gland (prostatitis), fever, dysentery, boils and ulcers, and various cancers.
Although preliminary lab tests show that a chemical in pau d'arco called lapachol can kill some viruses, bacteria, and fungi in test tubes, it isn't known whether it will have the same effects when taken by humans. So even though pau d'arco is sometimes used for conditions ranging from candidiasis (a yeast infection of the vaginal or oral areas), herpes simplex virus, and influenza to parasitic diseases such as schistosomiasis and bacterial infections such as brucellosis, there is no evidence it works. Test tube studies to evaluate whether pau d'arco has any effect on cancer have shown mixed results; and even in studies where pau d'arco does reduce the number of cancer cells, the amounts used would be toxic to humans.
The same is also true of some of the doses that might be needed to kill bacteria or viruses. If you decide to take pau d'arco, do so only under your doctor's supervision.
The pau d'arco tree is an evergreen tree that grows in the warm parts of Central and South America. It is a broad-leaf evergreen that grows to a height of 125 feet and has pink to violet-colored flowers. Its extremely hard wood makes it resistant to disease and decay. The inner bark of the tree is used medicinally. In recent years there has been an increasing demand for pau d'arco and, as a result, the trees are endangered.
Most of the chemical research on pau d'arco has been done on the wood and not the inner bark. Pau d'arco contains chemical compounds called naphthoquinones such as lapachol that may have antifungal, antiviral, and antibacterial properties, as well as significant amounts of the antioxidant quercetin.
Pau d'arco is sold as tablets, dried bark tea, and tincture (which contains alcohol). The chemicals that give pau d'arco its medicinal effects dissolve poorly in water, so a tea is not recommended.
Most pau d'arco products are not standardized, so it is not possible to determine whether or not they contain an appropriate amount of these active substances. It is important to carefully read the label to make sure that the product actually contains Tabebuia avellanedae as an ingredient.
Pediatric
Pau d'arco should not be given to infants or children.
Adult
It is important to discuss the dose with your doctor, since large amounts of pau d'arco can be toxic.
The use of herbs is a time-honored approach to strengthening the body and treating disease. Herbs, however, can trigger side effects and can interact with other herbs, supplements, or medications. For these reasons, herbs should be taken with care, under the supervision of a health care practitioner.
Talk to your doctor to determine the proper dose of pau d'arco, because too much can be dangerous.
At recommended doses, side effects are uncommon but may include anemia, nausea, diarrhea, and dizziness.
Pregnant and nursing women should not take pau d'arco.
Antiplatelet and anticoagulant drugs (blood-thinners) — Pau d'arco may affect the blood's ability to clot, and could interfere with any blood-thinning drugs you are taking, including:
Ipe roxo; LaPacho; Tabebuia avellanedae; Taheboo tree
Anesini C, Perez C. Screening of plants used in Argentine folk medicine for antimicrobial activity. J Ethnopharmacol. 1993;39:119–128.
Colman de Saizarbitoria T, Anderson JE, Alfonso D, McLaughlin JL. Bioactive furonaphtoquinones from Tabebuia barbata (Bignoniaceae). Acta Cient Venez. 1997;48(1):42-46.
de Miranda FG, Vilar JC, Alves IA, Cavalcanti SC, Antoniolli AR. Antinociceptive and antiedematogenic properties and acute toxicity of Tabebuia avellanedae Lor. ex Griseb. inner bark aqueous extract. BMC Pharmacol. 2001;1(1):6.
Dinnen RD, Ebisuzaki K. The search for novel anticancer agents: a differentiation-based assay and analysis of a folklore product. Anticancer Res. 1997;(2A):1027–1033.
Machado TB, Pinto AV, Pinto MC, et al. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. International Journal of Antimicrobial Agents. 2003;21(3):279-284.
Muller K, Sellmer A, Wiegrebe W. Potential antipsoriatic agents: lapacho compounds as potent inhibitors of HaCaT cell growth. J Nat Prod. 1999;62(8):1134-1136.
Park BS, Lee HK, Lee SE, Piao XL, Takeoka GR, Wong RY, et al. Antibacterial activity of Tabebuia impetiginosa Martius ex DC (Taheebo) against Helicobacter pylori. J Ethnopharmacol. 2006 Apr 21;105(1-2):255-62.
Pereira EM, Machado Tde B, Leal IC, et al. Tabebuia avellanedae naphthoquinones: activity against methicillin-resistant staphylococcal strains, cytotoxic activity and in vivo dermal irritability analysis. Ann Clin Microbiol Antimicrob. 2006 March 22;5:5.
Pinto CN, Dantas AP, De Moura KC, et al. Chemical reactivity studies with naphthoquinones from Tabebuia with anti-trypanosomal efficacy. Arzneimittelforschung. 2000;50(12):1120-1128.
Pizzorno JE, Murray MT. Textbook of Natural Medicine. New York: Churchill Livingstone; 1999:967-974.
Portillo A, Vila R, Freixa B, Adzet T, Canigueral S. Antifungal activity of Paraguayan plants used in traditional medicine. J Ethnopharmacol.2001;76(1):93-98.
Robbers JE, Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: The Haworth Herbal Press; 1999:246-247.
Ueda S, Umemura T, Dohguchi K, et al. Production of anti-tumour-promoting furanonaphthoquinones in Tabebuia avellanedae cell cultures. Phytochemistry. 1994;36:323–325.